Versions :<1 2 3 4 5 6 Live

Study: GLP-1 drugs Linked to 42% Lower Mental Illness Risk

Are GLP-1 drugs a dangerous lifetime dependency or a revolutionary breakthrough for physical and mental health?

Published 1 day ago

Study: GLP-1 drugs Linked to 42% Lower Mental Illness Risk

story

Image credit: Peter Dazeley/Getty Images

The Spin

Narrative A

Semaglutide isn't just a weight-loss drug — it's linked to a 42% lower risk of worsening mental health, a 44% drop in worsening depression and a 47% reduction in substance use disorder. For diabetic patients already facing two to three times higher depression rates, that's a game-changer. The mental health case for GLP-1 drugs is now impossible to dismiss.

Health And Me Scimex

Narrative B

GLP-1 drugs might show promising numbers, but stopping them triggers "metabolic whiplash" — undoing all cardiovascular benefits in half the time it took to build them. These aren't temporary fixes; they're lifetime dependencies that erode self-regulation and personal discipline. Real health has always required effort, and no pill changes that fundamental truth.

Suneel Dhand MD on X

Metaculus Prediction

Articles on this story

Stopping GLP-1 Drugs Could Put Your Heart At Risk

Time Magazine1 day

expert reaction to observational study on GLP-1 receptor agonists and lower risk of worsening mental illness, as published in The Lancet Psychiatry

Science Media Centre1 day

Some Ozempic-like drugs may help prevent depression, anxiety and self harm from worsening

Weight-loss drugs may lower the risk of depression, anxiety, and self-harm, study finds

GLP-1 diabetes drugs could stop anxiety and depression worsening, study finds

GLP-1s Tied to Lower Risk of Psychiatric Decline in Pre-existing Mental Illness

Association between GLP-1 receptor agonist use and worsening mental illness in people with depression and anxiety in Sweden: a national cohort study

The Lancet1 day

Fat Jabs Lower Risk Of Depression

The Telegraph1 day

Weight-Loss Medications May Reduce the Risk of Worsening Mental Disorders

BGNES News Agency1 day

Ozempic may reduce depression and anxiety risks in diabetics: The Lancet

Health And Me1 day

Bias Split Public Figures Controversies

Sign Up for Our Free Newsletters
Sign Up for Our Free Newsletters

About Contact Us Newsletter Archive Media

FAQ Glossary Privacy Policy

© 2026 Improve the News Foundation. All rights reserved.Version 6.18.0

© 2026 Improve the News Foundation.

All rights reserved.

Version 6.18.0